Plasma Tissue Factor Pathway Inhibitor and Tissue Factor Antigen Levels After Administration of Heparin in Patients With Angina Pectoris - Relationship between free and endothelial cell-associated forms of TFPI

By Soejima H.   Ogawa H.   Yasue H.   Nishiyama K.   Kaikita K.   Misumi K.   Takazoe K.   Kugiyama K.   Tsuji I.   Kumeda K.   Nakamura S.  

Thrombosis Research, Vol. 93, Iss. 1, 1999-01 ,pp. : 17-25

Elsevier

Access to resources Recommend Favorite

Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients

By Gando S.   Kameue T.   Matsuda N.   Hayakawa M.   Morimoto Y.   Ishitani T.   Kemmotsu O.  

Thrombosis Research, Vol. 109, Iss. 2, 2003-01 ,pp. : 119-124

Elsevier

Access to resources Recommend Favorite

Tissue Factor and Tissue Factor Pathway Inhibitor Levels during and after Cardiopulmonary Resuscitation - Role of elastase inhibitor

By Gando S.   Nanzaki S.   Morimoto Y.   Kobayashi S.   Kemmotsu O.  

Thrombosis Research, Vol. 96, Iss. 2, 1999-10 ,pp. : 107-113

Elsevier

Access to resources Recommend Favorite

Plasma tissue factor pathway inhibitor in disseminated intravascular coagulation: comparison of its behavior with plasma tissue factor

By Takahashi H.   Sato N.   Shibata A.  

Thrombosis Research, Vol. 80, Iss. 4, 1995-11 ,pp. : 339-348

Elsevier

Access to resources Recommend Favorite

Tissue factor pathway inhibitor (TFPI) activity in uremic patients during hemodialysis

By Cella G.   Vianello A.   Rampin E.   Sbarai A.   Boeri G.   Vertolli U.   Naso A.   Strauss W.E.  

Thrombosis Research, Vol. 81, Iss. 6, 1996-03 ,pp. : 671-677

Elsevier

Access to resources Recommend Favorite